Wells Fargo Maintains Equal-Weight on Exelixis, Raises Price Target to $49
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Wells Fargo analyst Eva Fortea Verdejo maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $40 to $49.
Wells Fargo analyst Eva Fortea Verdejo maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $40 to $49.